COVID-19 in Indonesia: Where Are We?

Since the 1st case officially confirmed on the last March 2020, Indonesia recorded more than 1000 new cases daily. The national trend shows no sign of decrease as 19 September 2020 the report sets a new mark of 4000 new cases in a day. The concept of controlling disease transmission relies on conta...

Full description

Saved in:
Bibliographic Details
Main Authors: Iwan Ariawan, Hafizah Jusril
Format: Article
Language:English
Published: Interna Publishing 2020-10-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:https://www.actamedindones.org/index.php/ijim/article/view/1578
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850061422173618176
author Iwan Ariawan
Hafizah Jusril
author_facet Iwan Ariawan
Hafizah Jusril
author_sort Iwan Ariawan
collection DOAJ
description Since the 1st case officially confirmed on the last March 2020, Indonesia recorded more than 1000 new cases daily. The national trend shows no sign of decrease as 19 September 2020 the report sets a new mark of 4000 new cases in a day. The concept of controlling disease transmission relies on contacts suppression; and on the longer end, relies on vaccinations. As 27 September 2020, no vaccine is approved for use in the general population. Until then, countries should implement early, widespread, and strict disease mitigation strategies. While much remains to be learned on COVID-19, global evidence assert at least three strategies at the population level contributes to flatten the curve: mobility restriction, testing and isolation and rigorous contact-tracing. Indonesia is not on entire absences of actions, but the epidemic calls for more. The central government called for social distancing two weeks after the first case confirmed and regulation on the large scale social distancing (Pembatasan Sosial Berskala Besar/ PSBB) that restrict non-essential population mobility is enacted by April 2020. Recent evidence outlines test, tracing and isolation are effective in suppressing COVID-19 transmission. Minimizing testing and tracing delay, less than four days with coverage of 80% close contacts could prevent and reduce onwards transmission. That we need to more is indisputable. The vaccine is not a magic bullet; it is a long-term control measure and should be a complete series of careful and precise examinations. Indonesia will also likely require high coverage of vaccination to achieve herd immunity. At present, if there is no significant improvement in the coverage of preventive measures in the population and disease surveillance system, our hospital will be overwhelmed, and case fatality will be devastating.
format Article
id doaj-art-e45ac6031bd94d409e427d984c5345bf
institution DOAJ
issn 0125-9326
2338-2732
language English
publishDate 2020-10-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj-art-e45ac6031bd94d409e427d984c5345bf2025-08-20T02:50:15ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322020-10-01523COVID-19 in Indonesia: Where Are We?Iwan Ariawan0Hafizah Jusril11. Faculty of Public Health, Universitas Indonesia, Depok, Indonesia. 2. Reconstra Utama Integra, Jakarta, Indonesia.1. Faculty of Public Health, Universitas Indonesia, Depok, Indonesia. 2. Reconstra Utama Integra, Jakarta, Indonesia. Since the 1st case officially confirmed on the last March 2020, Indonesia recorded more than 1000 new cases daily. The national trend shows no sign of decrease as 19 September 2020 the report sets a new mark of 4000 new cases in a day. The concept of controlling disease transmission relies on contacts suppression; and on the longer end, relies on vaccinations. As 27 September 2020, no vaccine is approved for use in the general population. Until then, countries should implement early, widespread, and strict disease mitigation strategies. While much remains to be learned on COVID-19, global evidence assert at least three strategies at the population level contributes to flatten the curve: mobility restriction, testing and isolation and rigorous contact-tracing. Indonesia is not on entire absences of actions, but the epidemic calls for more. The central government called for social distancing two weeks after the first case confirmed and regulation on the large scale social distancing (Pembatasan Sosial Berskala Besar/ PSBB) that restrict non-essential population mobility is enacted by April 2020. Recent evidence outlines test, tracing and isolation are effective in suppressing COVID-19 transmission. Minimizing testing and tracing delay, less than four days with coverage of 80% close contacts could prevent and reduce onwards transmission. That we need to more is indisputable. The vaccine is not a magic bullet; it is a long-term control measure and should be a complete series of careful and precise examinations. Indonesia will also likely require high coverage of vaccination to achieve herd immunity. At present, if there is no significant improvement in the coverage of preventive measures in the population and disease surveillance system, our hospital will be overwhelmed, and case fatality will be devastating. https://www.actamedindones.org/index.php/ijim/article/view/1578COVID-19Indonesiahealth systemtesttracingtreatment
spellingShingle Iwan Ariawan
Hafizah Jusril
COVID-19 in Indonesia: Where Are We?
Acta Medica Indonesiana
COVID-19
Indonesia
health system
test
tracing
treatment
title COVID-19 in Indonesia: Where Are We?
title_full COVID-19 in Indonesia: Where Are We?
title_fullStr COVID-19 in Indonesia: Where Are We?
title_full_unstemmed COVID-19 in Indonesia: Where Are We?
title_short COVID-19 in Indonesia: Where Are We?
title_sort covid 19 in indonesia where are we
topic COVID-19
Indonesia
health system
test
tracing
treatment
url https://www.actamedindones.org/index.php/ijim/article/view/1578
work_keys_str_mv AT iwanariawan covid19inindonesiawherearewe
AT hafizahjusril covid19inindonesiawherearewe